Menten AI

5个月前更新 13 0 0

Building the world's most advanced generative AI platform for peptide therapeutics.

所在地:
日本
收录时间:
2024-12-13
Menten AIMenten AI
Menten AI is a biotechnology company developing a generative AI platform for the design and optimization of peptide macrocycles, focusing on challenging drug targets that are currently undruggable or difficult to address with traditional methods. The platform combines advanced machine learning techniques with physics-based models and quantum chemistry simulations to accelerate the discovery of potent and membrane-permeable peptide macrocycles. Key features include:
  • Rapid Drug Design: Menten AI delivers drug-like hit molecules in just 8 weeks, compared to the industry standard of 1-2 years.
  • High Sampling Power: The platform explores a vast chemical space (10^50 compared to 10^9 for high-throughput platforms), achieving 10,000x greater sampling power in ⅙ the time.
  • High In Vitro Hit Rate: It boasts an in vitro hit success rate of over 50%, significantly higher than the industry average of ~9%.
  • Versatile Applications: The platform has been validated across a variety of drug targets, including anti-viral peptides and protein-protein interfaces (PPIs).
Menten AI is ideal for biopharmaceutical researchers and companies seeking to develop next-generation therapeutics for complex targets.

数据评估

Menten AI浏览人数已经达到13,如你需要查询该站的相关权重信息,可以点击"5118数据""爱站数据""Chinaz数据"进入;以目前的网站数据参考,建议大家请以爱站数据为准,更多网站价值评估因素如:Menten AI的访问速度、搜索引擎收录以及索引量、用户体验等;当然要评估一个站的价值,最主要还是需要根据您自身的需求以及需要,一些确切的数据则需要找Menten AI的站长进行洽谈提供。如该站的IP、PV、跳出率等!

关于Menten AI特别声明

本站AI产品库AIProductHub提供的Menten AI都来源于网络,不保证外部链接的准确性和完整性,同时,对于该外部链接的指向,不由AI产品库AIProductHub实际控制,在2024年12月13日 下午3:38收录时,该网页上的内容,都属于合规合法,后期网页的内容如出现违规,可以直接联系网站管理员进行删除,AI产品库AIProductHub不承担任何责任。

相关导航

暂无评论

none
暂无评论...